Top Markets
#1 Derive Derive +35.91%
#2 Akedo Akedo +33.15%
#3 DogBull DogBull +29.82%
#4 MYX Finance MYX Finance +19.91%
#5 Tezos Tezos +19.87%
#6 MetaDAO MetaDAO +19.60%
#7 Bedrock Bedrock +14.84%
#8 Fake World Assets Fake World Assets +14.80%
#9 Kinetiq Kinetiq +14.78%
#10 Harmony Harmony +14.09%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rank in Stocks #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Share Price
$150.78
Last synced: 2026-09-18
Market Cap
$187.20B
Change (1 day)
-0.08%
Change (1 year)
32.15%
Country
US
Trade Gilead Sciences, Inc. (GILD)

Category

Healthcare
EPS for Gilead Sciences, Inc. (GILD)
EPS as of June 2026 TTM: $-2.60
According to Gilead Sciences, Inc. latest financial reports and stock price the company's current EPS (TTM) is $-2.60. At the end of 2024 the company had a EPS of $0.38 a decrease compared to its 2023 EPS that were of $4.54.
EPS history for Gilead Sciences, Inc. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-2.60 -138.01%
2025 $6.84 1,700.00%
2024 $0.38 -91.63%
2023 $4.54 24.04%
2022 $3.66 -26.21%
2021 $4.96 4,966.39%
2020 $0.10 -97.69%
2019 $4.24 0.95%
2018 $4.20 18.64%
2017 $3.54 -64.88%
2016 $10.08 -18.51%
2015 $12.37 55.60%
2014 $7.95 295.52%
2013 $2.01 17.54%
2012 $1.71 -5.52%
2011 $1.81 6.47%
2010 $1.70 16.44%
2009 $1.46 33.94%
2008 $1.09 25.29%
2007 $0.87 -233.85%
2006 $-0.65 -244.44%
2005 $0.45 73.08%
2004 $0.26 -680.36%
2003 $-0.04 -196.76%
2002 $0.05 32.29%
2001 $0.04 -189.74%
2000 $-0.04 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -1,248.08%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -432.69%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -236.54%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -884.19%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -148.46%
US